Nabriva Therapeutics plc Quarterly Return On Assets in % from Q3 2017 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nabriva Therapeutics plc quarterly/annual Return On Assets history and growth rate from Q3 2017 to Q2 2023.
  • Nabriva Therapeutics plc Return On Assets for the quarter ending June 30, 2023 was -192 %, a 199% decline year-over-year.
  • Nabriva Therapeutics plc annual Return On Assets for 2022 was -114 %, a 98.7% decline from 2021.
  • Nabriva Therapeutics plc annual Return On Assets for 2021 was -57.4 %, a 54.3% increase from 2020.
  • Nabriva Therapeutics plc annual Return On Assets for 2020 was -126 %, a 41.1% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -192 -127 -199% Apr 1, 2023 Jun 30, 2023
Q1 2023 -136 -78.7 -138% Jan 1, 2023 Mar 31, 2023
Q4 2022 -114 -56.6 -98.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -76 -8.73 -13% Jul 1, 2022 Sep 30, 2022
Q2 2022 -64.1 +13.8 +17.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -57.1 +35.6 +38.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -57.4 +68.3 +54.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -67.3 +49 +42.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -78 +31.7 +28.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -92.7 +18.4 +16.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -126 -36.6 -41.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -116 -23 -24.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -110 +12.8 +10.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -111 +6.52 +5.54% Jan 1, 2020 Mar 31, 2020
Q4 2019 -89 +22.9 +20.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -93.3 +14.1 +13.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -122 -47.3 -62.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -118 -42.1 -55.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -112 -29.8 -36.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -107 -32.6 -43.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -75.1 Apr 1, 2018 Jun 30, 2018
Q1 2018 -75.6 Jan 1, 2018 Mar 31, 2018
Q4 2017 -82.2 Oct 1, 2017 Dec 31, 2017
Q3 2017 -74.9 Jul 1, 2017 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.